RESEARCH-USE BIOSIMILAR ANTIBODY

Giloralimab

Monoclonal antibody · IgG1

TNFRSF5IgG1RUO

Giloralimab (ABBV-927) is a potent antiCD40 agonistic monoclonal antibody. Giloralimab has the potential for the research of cancer.

TARGETTNFRSF5
YMonoclonal antibody
CATALOGSC-BS-503
CATALOG NUMBERSC-BS-503
MOLECULAR WEIGHTApprox. 145.26 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Giloralimab (ABBV-927) is a potent antiCD40 agonistic monoclonal antibody. Giloralimab has the potential for the research of cancer.

Giloralimab is a recombinant research-use antibody directed against TNFRSF5.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Giloralimab | StellaCyte